Biopharmaceutical companies face ever-increasing challenges in bringing products to market as well as maximizing return on investment.  Commercial and strategic planning early in the product lifecycle can significantly increase the likelihood of regulatory approval as well as meaningful market adoption.  Yet in resource-constrained environments, critical investment in product and portfolio planning at the earliest stages of development is often challenging amidst competing scientific, clinical, and regulatory demands.    

Drawing on our experience across large and small biopharma, strategy consulting, and venture capital environments, we work with companies of all sizes to augment their internal capabilities and address commercial needs during the pre-clinical and clinical phases of product development.  And as a boutique consultancy, we offer clients cost-effective support within a flexible fee structure.

commercial advisory services for health ventures

hatch health is a boutique advisory firm serving

life-science and healthcare-focused companies 

We help our clients maximize the value of their products and portfolios through early-stage commercial support​